Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study to Evaluate the Efficacy and Safety of Polatuzumab Vedotin in Combination With Bendamustine and Rituximab Compared With Bendamustine and Rituximab Alone in Chinese Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL).

    • Cancer
    • Non Hodgkin Lymphoma (NHL)
    • Diffuse Large B-Cell Lymphoma (DLBCL)